GSK's ViiV unit adds new HIV drug to AIDS patent pool

GlaxoSmithKline's AIDS drugs business is to add one of its latest HIV medicines to a patent pool - cutting its future price for developing countries and pooling intellectual property rights.

http://ift.tt/PepN6k